7
6
aberrant keratotic lesions1 on the dorsum of the hands,
feet, knees, and elbows, a cobblestone hyperkeratosis
of the knuckles, excessive perspiration and thickened
nails. Low serum9 vitamin A has been found in some
cases and Goette described the successful use of topi-
cal vitamin A. Histologic findings include orthokeratotic
hyperkeratosis associated with hypergra1nulosis or hy-
pogranulosis and moderate acanthosis. Changes are
nonspecific and common to many varieties of kerato-
epidermolytic palmoplantar keratoderma (NEPPK) is
caused by mutation in the KRT1 gene, and a focal form
of NE1P0,P14K can be caused by mutation in the KRT16
gene.
The use of DNA analysis and gene mapping in the diag-
nosis of PPK can therefore not be over-emphasized. It is
well known that there is a minimal role for the use of
vitamin A in the treatment of NEPPK resulting from
1
1
derma. An absence of epidermolysis differentiates it
Keratin-1 gene mutation. Unfortunately, this diagnostic
1
from EPPK. The hyperkeratosis may explain the appro-
tool is lacking in many resource- limited countries.
PPK can cause difficulty with walking. Repeated fungal
infections and odour can also result from the thick skin
and sweating of the feet. The thick skin on the palms
may reduce sensitivity in the fingertips, impairing
manual dexterity. All these problems, together with the
unusual appearance can be stressful and may lead to
psychological difficulties. In many resource poor coun-
tries including Nigeria, PPK like any other chronic dis-
priateness of the keratolytic agents in the therapy of
PPK.
1
0
Epidermolytic PPK (EPPK) - also known as Vorner
PPK- is another common form of autosomal dominant
PPK and the clinical presentation simulates the NEPPK
1
, 10
Some clinical 1,f1e0atures may help differentiate
NEPPK from EPPK. NEPPK may have a waxy ap-
pearance, compared with the dirty appearance of EPPK.
Hyperhidrosis and pitted keratolysis may also be present
1
order, may become stigmatized and
its erroneous
“supernatural cause” can cause disputes within the ex-
tended family structure. PPK may also be seen as “a
punishment for an ancestral sin “. The paediatrician can
thus serve to give appropriate and correct information
and genetic counseling.
1, 10
with NEPPK.
Furthermore, in NEPPK, secondary
dermatophyte infectio1,n10s, resulting in maceration and
peeling, are common.
1
1
Progressive PPK (Greither disease, Transgrediens et
progrediens PPK) is also an autosomal dominant diffuse
isolated PPK. Onset also1,1i1s in early infancy but may
The most common therapeutic options for PPK only
result in short-term improvement and are fre1quently
compounded by unacceptable adverse effects. Treat-
ment varies from saltwater soaks to topical keratolytics,
systemic retinoids, or reconstructive surgery with total
e1 xcision of the hyperkeratotic skin followed by grafting.
Topical keratolytics (e.g., salicylic acid , lactic acid,
occur later in childhood.
Clinically, diffuse PPK ex-
tends onto the dorsa of the hands and the feet
trangredient), with characteristic involvement of the
(
Achilles tendon, thus d1i,s1t1inguishing it clinically from
both NEPPK and EPPK.
1
Other diffuse PPK but which are inherited in an auto-
somal recessive pattern in1,c12lude the Mal de Meleda and
the Nagashimi-type PPK.
urea ) are useful in patients with limited keratoderma.
Potent topical steroids with or without keratolytics 1is
useful in dermatoses with an inflammatory component.
Molecular knowledge of palmoplantar epidermis has
identified keratin 9 (K9) Keratin1 (K1) and Ke13ratin 16
(
K16) in the supra-basal layers of epidermis. It thus
becomes obvious why mutations in the genes encoding
these proteins are associated with the skin disorders of
PPK. For example, epidermolytic palmoplantar kerato-
derma (EPPK) are caused by mutatio1n,10i,n14 the keratin-9
Conclusion
The case has added to the pool of rather uncommon
reports of Palmoplantar hyperkeratosis from Nigeria.
gene (KRT9) on chromosome 17q12.
A mild form
of EPPK can be caused by mutation in0,the14 keratin-1
Conflict of interest: None
Funding: None
1
gene (KRT1) on chromosome 12q.
Non -
References
3
.
Stevens H P, Kelsell DP, Bryant S
P, Bishop D T, Spurr N K , Weis-
senbach J, Marger D, Marger,
RS , Leigh I M. Linkage of an
American pedigree with palmo-
plantar keratoderma and malig-
nancy (palmoplantar ectodermal
dysplasia type III) to 17q24: litera-
ture survey and proposed updated
classification of the keratodermas.
Arch Derm 1996; 132: 640-651.
4. Patel S, Zirwas M, English JC.
"Acquired palmoplantar kerato-
derma" Am J Clin Dermatol
2007; 8 (1): 1–11.
5. Yusuf SM, Mijinyawa MS, Mai-
yaki MB, Mohammed AZ. Ich-
thyosis hystrix Curth-Macklin type
in an African girl. Int J Dermatol
2009: 48 (12): 1343-5.
6. Kulasekara B. Hyperkeratosis
palmoplantaris (Papillon-Lefèvre
syndrome). A case report Trop.
Georgr Med 1988; 40(3):257-8
1
2
.
.
Lee RA, Elston DM. Keratosis
Palmaris et Plantaris. eMedicine.
Available at: http://
emedicine.medscape.com/
article/1108406-otvherview#a1.
Accessed May 25 ,2013.
Lucker G PH, van de Kerkhof PC
M, Steijlen P M. The hereditary
palmoplantar keratoses: an updated
review and classification. Brit J
Derm 1994; 131: 1-14.